Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) EPS (Weighted Average and Diluted) (2016 - 2025)

Sanara MedTech's EPS (Weighted Average and Diluted) history spans 9 years, with the latest figure at -$0.13 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 218.18% year-over-year to -$0.13; the TTM value through Dec 2025 reached -$4.17, down 686.79%, while the annual FY2025 figure was -$0.05, 78.26% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.13 in Q4 2025 per SMTI's latest filing, up from -$3.4 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.11 in Q4 2024 to a low of -$3.4 in Q3 2025.
  • Average EPS (Weighted Average and Diluted) over 4 years is -$0.39, with a median of -$0.18 recorded in 2022.
  • Peak YoY movement for EPS (Weighted Average and Diluted): surged 466.67% in 2024, then crashed 16900.0% in 2025.
  • A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.51 in 2022, then soared by 94.12% to -$0.03 in 2023, then soared by 466.67% to $0.11 in 2024, then crashed by 218.18% to -$0.13 in 2025.
  • Per Business Quant, the three most recent readings for SMTI's EPS (Weighted Average and Diluted) are -$0.13 (Q4 2025), -$3.4 (Q3 2025), and -$0.23 (Q2 2025).